Skip to main content
Top
Published in: Strahlentherapie und Onkologie 9/2014

01-09-2014 | Original article

Evaluating the attendance of medical staff and room occupancy during palliative radiotherapy

Authors: Irenäus A. Adamietz, M.D., Oliver Micke, Wolfgang Popp, Horst Sack

Published in: Strahlentherapie und Onkologie | Issue 9/2014

Login to get access

Abstract

Introduction

Attendance of staff and use of resources during treatment have an impact on costs. For palliative radiotherapy, no reliable data are available on the subject. Therefore, the measurement of selected variables (staff absorbance and room occupancy) based on daily palliative irradiation was the aim of our prospective study. The analysis is part of a larger study conducted by the German Society of Radiation Oncology (DEGRO).

Patients, material, and methods

A total of 172 palliative radiation treatments were followed up prospectively between October 2009 and March 2010. The study was performed at two experienced radiotherapy departments (Herne and Bielefeld) and evaluated the attendance of medical personnel and room occupancy related to the selected steps of the treatment procedure: treatment planning and daily application of radiation dose.

Results

Computed tomography for treatment planning engaged the unit for 19 min (range: 17–22 min). The localization of target volume required on average 28 min of a technician’s working time. The mean attendance of the entire staff (radiation oncologist, physicist, technician) for treatment planning was 159 min, while the total room occupancy was 140 min. Depending on the type of treatment, the overall duration of a radiotherapy session varied on average between 8 and 18 min. The staff was absorbed by the first treatment session (including portal imaging) for 8–27 min. Mean room occupancy was 18 min (range: 6–65 min). The longest medical staff attendance was observed during an initial irradiation session (mean: 11 min). Radiotherapy sessions with weekly performed field verifications occupied the rooms slightly longer (mean: 10 min, range: 4–25 min) than daily radiotherapy sessions (mean: 9 min, range: 3–29 min). We observed that the patients’ symptoms, their condition, and their social environment confounded the time schedule.

Conclusions

Target localization, treatment planning, and performance of palliative radiotherapy absorb resources to an extent comparable to nonpalliative treatment. Because of unexpected events, the time schedule before and during radiotherapy may reveal strong interindividual variability.
Literature
1.
go back to reference Adamietz IA, Schneider O, Muller RP (2002) Results of a nationwide survey on radiotherapy of bone metastases in Germany. Strahlenther Onkol 178:531–536PubMedCrossRef Adamietz IA, Schneider O, Muller RP (2002) Results of a nationwide survey on radiotherapy of bone metastases in Germany. Strahlenther Onkol 178:531–536PubMedCrossRef
2.
go back to reference Blank E, Willich N, Fietkau R, Popp W, Schaller-Steiner J, Sack H, Wenz F (2012) Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients—The DEGRO-QUIRO Trial. Strahlenther Onkol 188:113–119PubMedCrossRef Blank E, Willich N, Fietkau R, Popp W, Schaller-Steiner J, Sack H, Wenz F (2012) Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients—The DEGRO-QUIRO Trial. Strahlenther Onkol 188:113–119PubMedCrossRef
3.
go back to reference Bradley NM, Husted J, Sey MS et al (2007) Review of patterns of practice and patients’ preferences in the treatment of bone metastases with palliative radiotherapy. Support Care Cancer 15:373–385PubMed Bradley NM, Husted J, Sey MS et al (2007) Review of patterns of practice and patients’ preferences in the treatment of bone metastases with palliative radiotherapy. Support Care Cancer 15:373–385PubMed
4.
go back to reference Budach W, Bölke E, Fietkau R, Buchali A, Wendt TG, Popp W, Matuschek C, Sack H (2011) Evaluation of Time, Attendance of Medical Staff, and Resources During Radiotherapy for Head and Neck Cancer Patients -The DEGRO-QUIRO Trial. Strahlenther Onkol 187:449–460PubMedCrossRef Budach W, Bölke E, Fietkau R, Buchali A, Wendt TG, Popp W, Matuschek C, Sack H (2011) Evaluation of Time, Attendance of Medical Staff, and Resources During Radiotherapy for Head and Neck Cancer Patients -The DEGRO-QUIRO Trial. Strahlenther Onkol 187:449–460PubMedCrossRef
5.
go back to reference Chow E (2007) Update on radiation treatment for cancer pain. Curr Opin Support Palliat Care 1:11–15PubMedCrossRef Chow E (2007) Update on radiation treatment for cancer pain. Curr Opin Support Palliat Care 1:11–15PubMedCrossRef
6.
go back to reference Christian E, Adamietz IA, Willich N et al (2008) Radiotherapy in oncological emergencies–final results of a patterns of care study in Germany, Austria and Switzerland. Acta Oncol 47:81–89PubMedCrossRef Christian E, Adamietz IA, Willich N et al (2008) Radiotherapy in oncological emergencies–final results of a patterns of care study in Germany, Austria and Switzerland. Acta Oncol 47:81–89PubMedCrossRef
7.
go back to reference Coia LR, Hanks GE, Martz K, Steinfeld A, Diamond JJ, Kramer S (1988) Practice patterns of palliative care for the United States 1984–1985. Int J Radiat Oncol Biol Phys 14:1261–1269PubMedCrossRef Coia LR, Hanks GE, Martz K, Steinfeld A, Diamond JJ, Kramer S (1988) Practice patterns of palliative care for the United States 1984–1985. Int J Radiat Oncol Biol Phys 14:1261–1269PubMedCrossRef
8.
go back to reference Donato V, Montagna A, Musio D et al (1999) Radiotherapy in the symptomatic treatment of the oncological patients. Anticancer Res 19:3375–3382PubMed Donato V, Montagna A, Musio D et al (1999) Radiotherapy in the symptomatic treatment of the oncological patients. Anticancer Res 19:3375–3382PubMed
9.
go back to reference Fietkau R, Budach W, Zamboglou N, Thiel HJ, Sack H, Popp W (2012) Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial. Strahlenther Onkol 188:5–11PubMedCrossRef Fietkau R, Budach W, Zamboglou N, Thiel HJ, Sack H, Popp W (2012) Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial. Strahlenther Onkol 188:5–11PubMedCrossRef
10.
go back to reference Hoegler D (1997) Radiotherapy for palliation of symptoms in incurable cancer. Curr Probl Cancer 21:129–183PubMedCrossRef Hoegler D (1997) Radiotherapy for palliation of symptoms in incurable cancer. Curr Probl Cancer 21:129–183PubMedCrossRef
11.
go back to reference Huang J, Zhou S, Tyldesley S, Zhang-Solomans J, Mackillop WJ (2001) Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol 19:137–144PubMed Huang J, Zhou S, Tyldesley S, Zhang-Solomans J, Mackillop WJ (2001) Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol 19:137–144PubMed
12.
13.
go back to reference Lievens Y, Van den Bogaert W, Rijnders A et al (2000) Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system? Radiother Oncol 56:289–295PubMedCrossRef Lievens Y, Van den Bogaert W, Rijnders A et al (2000) Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system? Radiother Oncol 56:289–295PubMedCrossRef
14.
go back to reference Moore A, Straube S, Derry S et al (2008) Does this work for you? Individuals, averages, and evidence based medicine. BMJ 337:a2585PubMedCrossRef Moore A, Straube S, Derry S et al (2008) Does this work for you? Individuals, averages, and evidence based medicine. BMJ 337:a2585PubMedCrossRef
15.
go back to reference Nieder C, Milas L, Ang KK (2000) Tissue tolerance to reirradiation. Semin Radiat Oncol 10:200–209PubMedCrossRef Nieder C, Milas L, Ang KK (2000) Tissue tolerance to reirradiation. Semin Radiat Oncol 10:200–209PubMedCrossRef
17.
18.
go back to reference Richter MP, Coia LR (1985) Palliative radiation therapy. Semin Oncol 12:375–383PubMed Richter MP, Coia LR (1985) Palliative radiation therapy. Semin Oncol 12:375–383PubMed
19.
go back to reference Slotman BJ, Cottier B, Bentzen SM et al (2005) Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1. Radiother Oncol 75:349–354PubMedCrossRef Slotman BJ, Cottier B, Bentzen SM et al (2005) Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1. Radiother Oncol 75:349–354PubMedCrossRef
20.
21.
go back to reference Wee B, Hadley G, Derry S (2008) How useful are systematic reviews for informing palliative care practice? Survey of 25 Cochrane systematic reviews. BMC Palliat Care 7:13PubMedCentralPubMedCrossRef Wee B, Hadley G, Derry S (2008) How useful are systematic reviews for informing palliative care practice? Survey of 25 Cochrane systematic reviews. BMC Palliat Care 7:13PubMedCentralPubMedCrossRef
22.
go back to reference Zabel-du Bois A, Milker-Zabel S, Henzel M, Popp W, Debus J, Sack H, Engenhart-Cabillic R (2012) Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery—QUIRO-DEGRO Trial. Strahlenther Onkol. 188:769–776PubMedCrossRef Zabel-du Bois A, Milker-Zabel S, Henzel M, Popp W, Debus J, Sack H, Engenhart-Cabillic R (2012) Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery—QUIRO-DEGRO Trial. Strahlenther Onkol. 188:769–776PubMedCrossRef
Metadata
Title
Evaluating the attendance of medical staff and room occupancy during palliative radiotherapy
Authors
Irenäus A. Adamietz, M.D.
Oliver Micke
Wolfgang Popp
Horst Sack
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 9/2014
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-014-0671-8

Other articles of this Issue 9/2014

Strahlentherapie und Onkologie 9/2014 Go to the issue